Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
1997-1-7
pubmed:databankReference
pubmed:abstractText
We have reported previously that about 15% of anaplastic astrocytomas and glioblastomas show amplification and overexpression of one or more genes from chromosomal segment 12q13-q15 (G. Reifenberger et al., Cancer Res., 54, 4299-4303, 1994). The genes most frequently amplified and overexpressed were CDK4 (with coamplification of SAS) and MDM2. Because individual malignant gliomas showed CDK4/SAS amplification but no MDM2 amplification and vice versa, the possibility remained of a common amplification target gene located between CDK4 and MDM2. We have addressed this question by performing a detailed amplicon mapping of a series of 24 primary malignant gliomas and two glioblastoma cell lines with 12q13-q15 amplification. All tumors and cell lines were analyzed at eight gene loci and six anonymous loci from 12q13-q15, including seven loci located between CDK4 and MDM2. These studies revealed two centers of amplification, one at CDK4/SAS and the other at MDM2. A number of loci located close to either MDM2 or CDK4/SAS, including the genes GADD153, GLI, RAP1B, A2MR, and IFNG, were found to be coamplified in some tumors but not overexpressed consistently. All amplicons were discontinuous between CDK4/SAS and MDM2. Our results thus exclude a common amplification target between CDK4/SAS and MDM2 and provide additional evidence that these genes represent two independent targets of selection.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5141-5
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:8912848-Adult, pubmed-meshheading:8912848-Aged, pubmed-meshheading:8912848-Brain Neoplasms, pubmed-meshheading:8912848-Chromosome Mapping, pubmed-meshheading:8912848-Chromosomes, Human, Pair 12, pubmed-meshheading:8912848-Cyclin-Dependent Kinase 4, pubmed-meshheading:8912848-Cyclin-Dependent Kinases, pubmed-meshheading:8912848-DNA Probes, pubmed-meshheading:8912848-Female, pubmed-meshheading:8912848-Gene Amplification, pubmed-meshheading:8912848-Glioblastoma, pubmed-meshheading:8912848-Humans, pubmed-meshheading:8912848-Male, pubmed-meshheading:8912848-Middle Aged, pubmed-meshheading:8912848-Molecular Sequence Data, pubmed-meshheading:8912848-Neoplasm Proteins, pubmed-meshheading:8912848-Nuclear Proteins, pubmed-meshheading:8912848-Proto-Oncogene Proteins, pubmed-meshheading:8912848-Proto-Oncogene Proteins c-mdm2
pubmed:year
1996
pubmed:articleTitle
Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
pubmed:affiliation
Department of Neuropathology, Heinrich Heine University, Düsseldorf, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't